Skip to content
Biodatica
Start free

Investigator

Jiyoung Ahn

NEW YORK UNIVERSITY SCHOOL OF MEDICINE · funded by NHLBI, NIEHS, NCI

Companies
1

Resolved onto their grants.

Grants
5

Federal awards on file.

Non-dilutive funding
$3.3M

Summed across those awards.

First award
Dec 1, 1996

Latest Sep 12, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    Coronary Atherosclerotic Burden in AsA-NHPI: the Role of the Gut Microbiome

    $2.2M

    Sep 12, 2025NHLBINEW YORK UNIVERSITY SCHOOL OF MEDICINENIH RePORTER · 11103656 (opens the source filing in a new tab)

  2. U24

    Maintenance and Enhancement of the Asian American enriched Cohort

    $394k

    Sep 6, 2024NIEHSNEW YORK UNIVERSITY SCHOOL OF MEDICINENIH RePORTER · 11184288 (opens the source filing in a new tab)

  3. UH3

    Asian American Community Cohort of the New York Metropolitan Area

    $688k

    Aug 18, 2023NHLBINEW YORK UNIVERSITY SCHOOL OF MEDICINENIH RePORTER · 11225288 (opens the source filing in a new tab)

  4. P30

    Epidemiology & Cancer Control (ECC) Research Program

    $36k

    Dec 1, 1996NCINEW YORK UNIVERSITY SCHOOL OF MEDICINENIH RePORTER · 11075231 (opens the source filing in a new tab)

  5. P30

    Epidemiology & Cancer Control (ECC) Research Program

    $36k

    Dec 1, 1996NCINEW YORK UNIVERSITY SCHOOL OF MEDICINENIH RePORTER · 11317121 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources